m+Medelevator.RU
← Поиск публикаций
Acta paediatrica (Oslo, Norway : 1992) · 2016

Clinicians in 25 countries prefer to use lower levels of oxygen to resuscitate preterm infants at birth.

СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Oei Ju Lee, Ghadge Alpana, Coates Elisabeth, Wright Ian M, Saugstad Ola D, Vento Maximo, Buonocore Giuseppe, Nagashima Tatsuo, Suzuki Keiji, Hosono Shiguhero, Davis Peter G, Craven Paul, Askie Lisa, Dawson Jennifer, Garg Shalabh, Keech Anthony, Rabi Yacov, Smyth John, Sinha Sunil, Stenson Ben, Lui Kei, Hunter Carol Lu, Tarnow Mordi William, HOLISTIC (Higher Or Lower oxygen and Infant Saturation Targeting: International Collaboration) Study Group

Аннотация

AIM: This study determined current international clinical practice and opinions regarding initial fractional inspired oxygen (FiO2 ) and pulse oximetry (SpO2 ) targets for delivery room resuscitation of preterm infants of less than 29 weeks of gestation.

METHODS: An online survey was disseminated to neonatal clinicians via established professional clinical networks using a web-based survey programme between March 9 and June 30, 2015.

RESULTS: Of the 630 responses from 25 countries, 60% were from neonatologists. The majority (77%) would target SpO2 between the 10th to 50th percentiles values for full-term infants. The median starting FiO2 was 0.3, with Japan using the highest (0.4) and the UK using the lowest (0.21). New Zealand targeted the highest SpO2 percentiles (median 50%). Most respondents agreed or did not disagree that a trial was required that compared the higher FiO2 of 0.6 (83%), targeting the 50th SpO2 percentile (60%), and the lower FiO2 of 0.21 (80%), targeting the 10th SpO2 percentile (78%). Most (65%) would join this trial. Many considered that evidence was lacking and further research was needed.

CONCLUSION: Clinicians currently favour lower SpO2 targets for preterm resuscitation, despite acknowledging the lack of evidence for benefit or harm, and 65% would join a clinical trial.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты